• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环孢素重复治疗与强直性脊柱炎相关的外周关节炎。

Repeated cyclosporine therapy of peripheral arthritis associated with ankylosing spondylitis.

作者信息

Géher P, Gömör B

机构信息

Rheumatology and Physiotherapy, Semmelweis University of Medical Sciences, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary.

出版信息

Med Sci Monit. 2001 Jan-Feb;7(1):105-7.

PMID:11208503
Abstract

BACKGROUND

A case history of a patient with ankylosing spondylitis and peripheral arthritis unresponsive to the conventional drug therapy, but successfully controlled by the use of cyclosporin.

MATERIAL AND METHODS

In a 68 years old female patient with a 36 years history of typical ankylosing spondylitis a peripheral polyarthritis (hands, feet, wrists, and knees) developed. The patient did not suffer any other disease known to cause secondary spondylitis (psoriasis, inflammatory, bowel, disease). After the unsuccessful use of non-steroidal antiinflammatory drugs a combination therapy with cyclosporin (4 mg/kg/day) and azapropazone (300 mg t.i.d.) was introduced.

RESULTS

Clinical improvement was achieved after 6 months of combined therapy, the polyarthritis completely resolved after one year. Therefore cyclosporin was discontinued. After one year the polyarthritis reappeared therefore the cyclosporin therapy was reinstituted with success.

CONCLUSION

Cyclosporin has proved consistently effective in our case to control the peripheral arthritis associated with ankylosing spondylitis.

摘要

背景

一名强直性脊柱炎合并周围关节炎患者,对传统药物治疗无反应,但使用环孢素成功控制病情。

材料与方法

一名68岁女性患者,有36年典型强直性脊柱炎病史,出现周围多关节炎(手、足、腕和膝)。患者未患任何已知可引起继发性脊柱炎的其他疾病(银屑病、炎症性肠病)。在使用非甾体抗炎药治疗失败后,引入环孢素(4毫克/千克/天)和阿扎丙宗(300毫克,每日三次)联合治疗。

结果

联合治疗6个月后临床症状改善,多关节炎在1年后完全缓解。因此停用环孢素。1年后多关节炎复发,因此重新使用环孢素治疗并取得成功。

结论

在我们的病例中,环孢素已被证明能持续有效地控制与强直性脊柱炎相关的周围关节炎。

相似文献

1
Repeated cyclosporine therapy of peripheral arthritis associated with ankylosing spondylitis.环孢素重复治疗与强直性脊柱炎相关的外周关节炎。
Med Sci Monit. 2001 Jan-Feb;7(1):105-7.
2
Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection of infliximab.通过关节内注射英夫利昔单抗治疗强直性脊柱炎中的难治性炎性单关节炎。
J Rheumatol. 2006 Jan;33(1):82-5. Epub 2005 Nov 15.
3
Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy.强直性脊柱炎与症状改善疗法和疾病改善疗法
Best Pract Res Clin Rheumatol. 2006 Jun;20(3):539-57. doi: 10.1016/j.berh.2006.03.003.
4
Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations.巴斯强直性脊柱炎疾病活动指数与该指数的一个修订版本在评估无外周表现的强直性脊柱炎患者疾病活动度方面的比较。
Ann Rheum Dis. 2009 Nov;68(11):1701-7. doi: 10.1136/ard.2008.099226. Epub 2008 Nov 24.
5
Coexistence of ankylosing spondylitis and rheumatoid arthritis in a female patient.女性患者同时患有强直性脊柱炎和类风湿关节炎。
Clin Rheumatol. 2011 Aug;30(8):1119-22. doi: 10.1007/s10067-011-1740-3. Epub 2011 Apr 20.
6
Rapid remission of treatment-resistant ankylosing spondylitis with etanercept--a drug for refractory ankylosing spondylitis?依那西普使难治性强直性脊柱炎迅速缓解——一种用于难治性强直性脊柱炎的药物?
Arthritis Rheum. 2001 Aug;45(4):404. doi: 10.1002/1529-0131(200108)45:4<404::AID-ART355>3.0.CO;2-X.
7
Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.肿瘤坏死因子拮抗剂再次给药治疗活动性强直性脊柱炎患者的长期疗效及安全性
Rheumatology (Oxford). 2005 Mar;44(3):342-8. doi: 10.1093/rheumatology/keh475. Epub 2004 Nov 23.
8
[The effect of cyclosporin A (Sandimmun) on the level of soluble interleukin-2 receptors in rheumatoid arthritis].[环孢素A(山地明)对类风湿关节炎患者可溶性白细胞介素-2受体水平的影响]
Ter Arkh. 1997;69(8):19-21.
9
Six months open label trial of leflunomide in active ankylosing spondylitis.来氟米特治疗活动性强直性脊柱炎的六个月开放标签试验。
Ann Rheum Dis. 2005 Jan;64(1):124-6. doi: 10.1136/ard.2003.019174.
10
[ACR preliminary definition, of improvement in rheumatoid arthritis].[美国风湿病学会(ACR)对类风湿关节炎改善情况的初步定义]
Ryumachi. 1996 Dec;36(6):891-900.

引用本文的文献

1
Acquired pure red cell aplasia in a patient with ankylosing spondylitis- a case report and literature review.强直性脊柱炎患者获得性纯红细胞再生障碍性贫血——一例报告及文献复习
Medicine (Baltimore). 2019 Jul;98(27):e16160. doi: 10.1097/MD.0000000000016160.
2
Association of Genetic Variants in Pentraxin 3 Gene with Ankylosing Spondylitis.五聚体蛋白3基因中的遗传变异与强直性脊柱炎的关联
Med Sci Monit. 2016 Aug 18;22:2911-6. doi: 10.12659/msm.896562.
3
Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis.
强直性脊柱炎管理的当前证据:针对强直性脊柱炎ASAS/EULAR管理建议的系统文献综述
Ann Rheum Dis. 2006 Apr;65(4):423-32. doi: 10.1136/ard.2005.041129. Epub 2005 Aug 26.